FDA approves Zepbound for sleep apnea in obese adults
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
Hosted on MSN2h
Health Benefits or Negative Impacts Still Uncertain for Most Supplements
Lining grocery store shelves are supplements like omega fish oil, goat's rue and others that sound more like the ingredients ...
Changing your eye color with surgery is risky. They did it anyway.
Advances in cosmetic surgery let people permanently change their eye color, and they’ll pay thousands for a new hue. Doctors ...
For young users, tobacco packets like Zyn are a nicotine trend that just won’t quit
Promoted by users as a pick-me-up, nicotine may give young people a quick burst of energy. But in the long term, it has the ...
FDA announces recall of Systane eye drops due to fungal contamination
The FDA has issued a recall for specific lots of Systane eye drops due to potential fungal contamination after a consumer ...
FDA recalls hair spray brand in 12 states over solvent linked to health risks
Initially the hair spray brand was a voluntarily recalled by CRLAB USA, based in California, on Dec. 12 and became a Class II ...
'A win': Pensacola attorney praises FDA's proposed rule for testing talc-based cosmetics
For decades, women thought they could trust cosmetic products, like baby powder, for feminine hygiene.But many of those ...
After cat dies from bird flu infection, experts caution against raw pet food
Experts and some public officials are warning against raw pet foods after a cat in Oregon was found to have died from a ...
Could the FDA's Approach to Vaping Cause an Increase in Smoking?
In early December, the Supreme Court heard oral argument in Food and Drug Administration v. Wages and White Lion Investments, a challenge to the FDA's ...
News Nation on MSN5h
Weight loss drug Zepbound approved to help sleep apnea patients
( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...
STAT6h
Fixing pulse oximeters requires federal might and possible legal action, researchers say
The devices remain unreliable in darker skinned people. Researchers say more guidance, enforcement and even legal action may ...
STAT9h
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...